X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (49168) 49168
Newsletter (3681) 3681
Newspaper Article (733) 733
Magazine Article (529) 529
Transcript (176) 176
Dissertation (174) 174
Book Chapter (127) 127
Book / eBook (50) 50
Web Resource (32) 32
Publication (25) 25
Government Document (24) 24
Conference Proceeding (21) 21
Streaming Video (19) 19
Reference (14) 14
Book Review (10) 10
Pamphlet (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30325) 30325
hypercholesterolemia (27810) 27810
male (21684) 21684
female (17397) 17397
middle aged (13929) 13929
cholesterol (12751) 12751
adult (11117) 11117
animals (10688) 10688
risk factors (9016) 9016
atherosclerosis (8812) 8812
aged (8672) 8672
hypercholesterolemia - drug therapy (8422) 8422
cholesterol - blood (8335) 8335
hypercholesterolemia - blood (6572) 6572
familial hypercholesterolemia (5942) 5942
cardiac & cardiovascular systems (5666) 5666
hypercholesterolemia - complications (5554) 5554
low density lipoproteins (5549) 5549
cholesterol, ldl - blood (5362) 5362
research (5083) 5083
peripheral vascular disease (4811) 4811
lipids (4088) 4088
triglycerides - blood (3996) 3996
statins (3963) 3963
anticholesteremic agents - therapeutic use (3900) 3900
medicine, general & internal (3801) 3801
pharmacology & pharmacy (3357) 3357
lipids - blood (3353) 3353
risk (3205) 3205
mice (3152) 3152
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3132) 3132
hypertension (3115) 3115
rabbits (3041) 3041
biochemistry & molecular biology (3032) 3032
rats (2950) 2950
adolescent (2907) 2907
lipoproteins (2900) 2900
genetic aspects (2871) 2871
cardiovascular disease (2870) 2870
care and treatment (2857) 2857
health aspects (2770) 2770
cholesterol, hdl - blood (2762) 2762
hypercholesterolemia - metabolism (2759) 2759
disease (2753) 2753
analysis (2720) 2720
diet (2703) 2703
treatment outcome (2622) 2622
hypercholesterolemia - epidemiology (2570) 2570
simvastatin (2551) 2551
cardiovascular diseases (2511) 2511
coronary-heart-disease (2466) 2466
prevention (2461) 2461
low-density-lipoprotein (2447) 2447
coronary heart disease (2405) 2405
medical research (2263) 2263
child (2238) 2238
nutrition & dietetics (2196) 2196
prevalence (2160) 2160
physiological aspects (2124) 2124
drug therapy (2044) 2044
metabolism (2018) 2018
time factors (2004) 2004
diabetes (1995) 1995
cardiovascular-disease (1993) 1993
medicine, experimental (1945) 1945
hypercholesterolemia - prevention & control (1937) 1937
mortality (1903) 1903
cholesterol - metabolism (1896) 1896
cardiovascular (1892) 1892
endocrinology & metabolism (1835) 1835
hypercholesterolemia - physiopathology (1824) 1824
hypercholesterolemia - genetics (1810) 1810
lipoproteins - blood (1799) 1799
pravastatin (1766) 1766
disease models, animal (1756) 1756
atorvastatin (1718) 1718
aged, 80 and over (1672) 1672
plasma (1659) 1659
hypercholesterolemia - therapy (1650) 1650
hyperlipidemia (1648) 1648
hematology (1644) 1644
cardiovascular diseases - prevention & control (1632) 1632
double-blind method (1611) 1611
hypertension - complications (1610) 1610
hypercholesterolemia - diet therapy (1606) 1606
hypercholesterolemia - etiology (1602) 1602
medicine, research & experimental (1592) 1592
therapy (1591) 1591
myocardial-infarction (1587) 1587
risk-factors (1581) 1581
blood cholesterol (1580) 1580
coronary disease - prevention & control (1578) 1578
obesity (1575) 1575
inflammation (1573) 1573
heart-disease (1568) 1568
lipoproteins, ldl - blood (1549) 1549
follow-up studies (1526) 1526
expression (1514) 1514
age factors (1507) 1507
receptors, ldl - genetics (1504) 1504
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (30) 30
Online Resources - Online (29) 29
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Gerstein Science - Reference (2) 2
Scarborough Hospital - Birchmount (2) 2
Baycrest Hospital - Wellness Library (1) 1
Bridgepoint Health - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (48569) 48569
German (1285) 1285
Spanish (934) 934
French (919) 919
Russian (883) 883
Japanese (837) 837
Italian (507) 507
Polish (288) 288
Portuguese (277) 277
Chinese (169) 169
Czech (100) 100
Dutch (100) 100
Hungarian (85) 85
Korean (80) 80
Romanian (66) 66
Swedish (63) 63
Norwegian (54) 54
Danish (49) 49
Turkish (42) 42
Finnish (36) 36
Ukrainian (28) 28
Hebrew (17) 17
Slovak (17) 17
Persian (15) 15
Bulgarian (14) 14
Croatian (12) 12
Indonesian (9) 9
Lithuanian (7) 7
Serbian (7) 7
Afrikaans (3) 3
Arabic (2) 2
Slovenian (2) 2
Bosnian (1) 1
Catalan (1) 1
Estonian (1) 1
Icelandic (1) 1
Tagalog (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 16, pp. 1489 - 1499
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 169, Issue 6, pp. 906 - 915.e13
Journal Article
Journal of Pediatrics, The, ISSN 0022-3476, 2012, Volume 161, Issue 6, pp. 1004 - 1009
Objective To analyze the interplay among oxidative stress, NOX2, the catalytic core of nicotinamide-adenine dinucleotide phosphate oxidase, and endothelial... 
Pediatrics | NADPH | sNOX2-dp | Flow-mediated arterial dilation | Soluble NOX2-dp | Oxidized low-density lipoprotein | Obese children | ox-LDL | Intima media thickness | Isoprostanes | Low-density lipoprotein | Body mass index | IMT | LDL | Nitric oxide | Children with coexistence of hypercholesterolemia and obesity | Nicotinamide-adenine dinucleotide phosphate | Healthy subjects | Children with hypercholesterolemia | FMD | HOC | 8-iso-PGF2α | BMI | INTIMA-MEDIA THICKNESS | FAMILIAL HYPERCHOLESTEROLEMIA | ENDOTHELIAL DYSFUNCTION | OXIDANT STRESS | INSULIN-RESISTANCE | IN-VIVO | FOLLOW-UP | PEDIATRICS | CIRCULATING OXIDIZED LDL | BLOOD-PRESSURE | CARDIOVASCULAR RISK-FACTORS | Hypercholesterolemia - diagnostic imaging | Biomarkers - urine | Oxidative Stress | Humans | Male | Case-Control Studies | Vasodilation | Brachial Artery - diagnostic imaging | Brachial Artery - physiopathology | Female | Dinoprost - analogs & derivatives | Child | Obesity - diagnostic imaging | Cardiovascular Diseases - etiology | Cross-Sectional Studies | Dinoprost - urine | Carotid Intima-Media Thickness | Obesity - complications | Risk Factors | Membrane Glycoproteins - blood | Linear Models | NADPH Oxidases - blood | Obesity - physiopathology | Biomarkers - blood | NADPH Oxidase 2 | Obesity - metabolism | Adolescent | Hypercholesterolemia - complications | Hypercholesterolemia - physiopathology | Hypercholesterolemia - metabolism | Lipoproteins, LDL - blood | Oxidases | Phosphates | Oxidative stress | Obesity | Hypercholesterolemia | Analysis | Children | Health aspects
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 01/2015, Volume 35, Issue 1, pp. 50 - 59
Journal Article
Journal Article
Molecular therapy, ISSN 1525-0016, 2017, Volume 25, Issue 5, pp. 1069 - 1075
Oligonucleotides (oligos) have been under clinical development for approximately the past 30 years, beginning with antisense oligonucleotides (ASOs) and... 
Kynamro | therapeutics | Spinraza | Defitelio | Vitravene | Macugen | aptamer | phosphorothioate | Eteplirsen | oligonucleotide | MEDICINE, RESEARCH & EXPERIMENTAL | FAMILIAL HYPERCHOLESTEROLEMIA | VENOOCCLUSIVE DISEASE | B SYNTHESIS INHIBITOR | APOLIPOPROTEIN-B | LDL CHOLESTEROL | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ENDOTHELIAL-CELLS | GENETICS & HEREDITY | DUCHENNE MUSCULAR-DYSTROPHY | EXTRACELLULAR-MATRIX | FIBROBLAST GROWTH-FACTORS | RECEPTOR-BINDING | Oligonucleotides - therapeutic use | Humans | Morpholinos - therapeutic use | Polydeoxyribonucleotides - therapeutic use | Drug Approval | Hepatic Veno-Occlusive Disease - therapy | Cytomegalovirus Retinitis - virology | Muscular Atrophy, Spinal - genetics | Hypercholesterolemia - pathology | Oligonucleotides, Antisense - therapeutic use | Hepatic Veno-Occlusive Disease - genetics | Hypercholesterolemia - therapy | Hepatic Veno-Occlusive Disease - pathology | Muscular Dystrophy, Duchenne - therapy | Cytomegalovirus Retinitis - therapy | Thionucleotides - therapeutic use | Aptamers, Nucleotide - therapeutic use | Muscular Dystrophy, Duchenne - pathology | Clinical Trials as Topic | Cytomegalovirus Retinitis - genetics | Muscular Atrophy, Spinal - pathology | Macular Degeneration - genetics | Macular Degeneration - therapy | Muscular Atrophy, Spinal - therapy | Hypercholesterolemia - genetics | Muscular Dystrophy, Duchenne - genetics | Macular Degeneration - pathology | Macular degeneration | Cytomegalovirus | Collaboration | Clinical trials | Antisense oligonucleotides | FDA approval | Mutation | Drug dosages | Binding sites | Marketing | Pharmaceuticals | Review
Journal Article